Abivax Sa American Stock Performance
| ABVX Stock | 91.67 0.18 0.20% |
On a scale of 0 to 100, Abivax SA holds a performance score of 16. The firm shows a Beta (market volatility) of 22.68, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Abivax SA will likely underperform. Please check Abivax SA's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Abivax SA's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Abivax SA American are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Abivax SA showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 0.2 | Five Day Return (0.37) | Year To Date Return 1.2 K | Ten Year Return 1 K | All Time Return 1 K |
1 | Piper Sandler Raises Price Target for Abivax | 08/01/2025 |
2 | Earnings Scheduled For August 11, 2025 | 08/11/2025 |
3 | What technical models suggest about ABIVAX Socit Anonyme Depositary Receipts comeback - 2025 Momentum Check Fast Moving Stock Trade Plans - Newser | 08/25/2025 |
4 | Abivaxs Buy Rating Reiterated at BTIG Research | 09/12/2025 |
5 | Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology Meeting | 09/23/2025 |
6 | ABIVAX Socit Anonyme to Present Phase 3 UC Data at UEG Congress, Investor Call Scheduled | 09/30/2025 |
7 | Spotlight on Abivax Analyzing the Surge in Options Activity | 10/06/2025 |
| Begin Period Cash Flow | 251.9 M | |
| Total Cashflows From Investing Activities | 15.8 M |
Abivax SA Relative Risk vs. Return Landscape
If you would invest 6,976 in Abivax SA American on July 24, 2025 and sell it today you would earn a total of 2,191 from holding Abivax SA American or generate 31.41% return on investment over 90 days. Abivax SA American is currently generating 0.4582% in daily expected returns and assumes 2.1989% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than Abivax, and 91% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Abivax SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abivax SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abivax SA American, and traders can use it to determine the average amount a Abivax SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2084
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABVX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.2 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average Abivax SA is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abivax SA by adding it to a well-diversified portfolio.
Abivax SA Fundamentals Growth
Abivax Stock prices reflect investors' perceptions of the future prospects and financial health of Abivax SA, and Abivax SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abivax Stock performance.
| Return On Equity | -5.0 | ||||
| Return On Asset | -0.58 | ||||
| Operating Margin | (44.41) % | ||||
| Current Valuation | 6.42 B | ||||
| Shares Outstanding | 77.83 M | ||||
| Price To Book | 8.74 X | ||||
| Price To Sales | 1,187 X | ||||
| Revenue | 10.79 M | ||||
| Gross Profit | 6.02 M | ||||
| EBITDA | (171.88 M) | ||||
| Net Income | (176.24 M) | ||||
| Total Debt | 97.36 M | ||||
| Book Value Per Share | (0.76) X | ||||
| Cash Flow From Operations | (154.07 M) | ||||
| Earnings Per Share | (3.60) X | ||||
| Market Capitalization | 7.15 B | ||||
| Total Asset | 205.23 M | ||||
| Retained Earnings | (438.88 M) | ||||
| Working Capital | 77.84 M | ||||
About Abivax SA Performance
Evaluating Abivax SA's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Abivax SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abivax SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 56.4 K | 59.2 K | |
| Return On Tangible Assets | (0.98) | (1.03) | |
| Return On Capital Employed | (1.65) | (1.73) | |
| Return On Assets | (0.86) | (0.90) | |
| Return On Equity | (4.34) | (4.13) |
Things to note about Abivax SA American performance evaluation
Checking the ongoing alerts about Abivax SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abivax SA American help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 10.79 M. Net Loss for the year was (176.24 M) with profit before overhead, payroll, taxes, and interest of 6.02 M. | |
| Abivax SA generates negative cash flow from operations | |
| Abivax SA American has a poor financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: Spotlight on Abivax Analyzing the Surge in Options Activity |
- Analyzing Abivax SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abivax SA's stock is overvalued or undervalued compared to its peers.
- Examining Abivax SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abivax SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abivax SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abivax SA's stock. These opinions can provide insight into Abivax SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abivax Stock Analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.